96 related articles for article (PubMed ID: 20949451)
1. Rapid prescreening is as effective at reducing screening error as postscreening with the FocalPoint automated screening device.
Wilgenbusch H; Mueller G; Neal M; Renshaw AA
Diagn Cytopathol; 2011 Nov; 39(11):818-21. PubMed ID: 20949451
[TBL] [Abstract][Full Text] [Related]
2. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
[TBL] [Abstract][Full Text] [Related]
3. Rapid prescreening of Papanicolaou smears: a practical and efficient quality control strategy.
Djemli A; Khetani K; Auger M
Cancer; 2006 Feb; 108(1):21-6. PubMed ID: 16302251
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of rapid prescreening and 10% rescreening in liquid-based Papanicolaou testing.
Currens HS; Nejkauf K; Wagner L; Raab SS
Am J Clin Pathol; 2012 Jan; 137(1):150-5. PubMed ID: 22180489
[TBL] [Abstract][Full Text] [Related]
5. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.
Wilbur DC; Black-Schaffer WS; Luff RD; Abraham KP; Kemper C; Molina JT; Tench WD
Am J Clin Pathol; 2009 Nov; 132(5):767-75. PubMed ID: 19846820
[TBL] [Abstract][Full Text] [Related]
6. Rapid prescreen of cervical liquid-based cytology preparations: results of a study in an academic medical center.
Frable WJ; Pedigo MA; Powers CN; Yarrell C; Ortiz B; Clark ME; Ebron T
Diagn Cytopathol; 2012 Aug; 40(8):691-7. PubMed ID: 22807384
[TBL] [Abstract][Full Text] [Related]
7. Rapid pre-screening of cervical smears as a method of internal quality control in a cervical screening programme.
Tavares SB; de Sousa NL; Manrique EJ; de Albuquerque ZB; Zeferino LC; Amaral RG
Cytopathology; 2008 Aug; 19(4):254-9. PubMed ID: 18476988
[TBL] [Abstract][Full Text] [Related]
8. Performance of rapid prescreening and 100% rapid review as internal quality control methods for cervical cytopathology.
Tobias AHG; Vitalino AC; Rezende MT; Oliveira RRR; Coura-Vital W; Amaral RG; Carneiro CM
Cytopathology; 2018 Oct; 29(5):428-435. PubMed ID: 29904955
[TBL] [Abstract][Full Text] [Related]
9. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
Arbyn M; Schenck U; Ellison E; Hanselaar A
Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
[TBL] [Abstract][Full Text] [Related]
10. FocalPoint slide classification algorithms show robust performance in classification of high-grade lesions on SurePath liquid-based cervical cytology slides.
Parker EM; Foti JA; Wilbur DC
Diagn Cytopathol; 2004 Feb; 30(2):107-10. PubMed ID: 14755762
[TBL] [Abstract][Full Text] [Related]
11. Liquid-based cytology for cervical cancer screening.
Bentz JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL.
Cengel KA; Day SJ; Davis-Devine S; Adams CL; Madison-Henness D; Hartman ME; Freund GG
Diagn Cytopathol; 2003 Nov; 29(5):250-5. PubMed ID: 14595790
[TBL] [Abstract][Full Text] [Related]
13. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis.
Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N
Cancer; 2003 Apr; 99(2):83-8. PubMed ID: 12704687
[TBL] [Abstract][Full Text] [Related]
14. Implementation of FocalPoint GS location-guided imaging system: experience in a clinical setting.
Levi AW; Chhieng DC; Schofield K; Kowalski D; Harigopal M
Cancer Cytopathol; 2012 Apr; 120(2):126-33. PubMed ID: 22505211
[TBL] [Abstract][Full Text] [Related]
15. Improved sensitivity over time with rapid prescreening in gynecologic cytology.
Dudding N; Renshaw AA; Ellis K
Diagn Cytopathol; 2011 Jun; 39(6):428-30. PubMed ID: 21574262
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 100% rapid rescreening of negative cervical smears as a quality assurance measure.
Manrique EJ; Amaral RG; Souza NL; Tavares SB; Albuquerque ZB; Zeferino LC
Cytopathology; 2006 Jun; 17(3):116-20. PubMed ID: 16719853
[TBL] [Abstract][Full Text] [Related]
17. One hundred percent thorough quality control rescreening of liquid-based monolayers in cervicovaginal cytopathology.
Rowe LR; Marshall CJ; Bentz JS
Cancer; 2002 Dec; 96(6):325-9. PubMed ID: 12478679
[TBL] [Abstract][Full Text] [Related]
18. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
Renshaw AA; Deschênes M; Auger M
Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
[TBL] [Abstract][Full Text] [Related]
19. Individual estimated sensitivity and workload for manual screening of SurePath gynecologic cytology.
Ellis K; Renshaw AA; Dudding N
Diagn Cytopathol; 2012 Feb; 40(2):95-7. PubMed ID: 22246923
[TBL] [Abstract][Full Text] [Related]
20. Automated prescreening of conventionally prepared cervical smears: a feasibility study.
Bartoo GT; Lee JS; Bartels PH; Kiviat NB; Nelson AC
Lab Invest; 1992 Jan; 66(1):116-22. PubMed ID: 1731146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
